Bioequivalence Study of Feniramidol HCl 400 mg Film Tablet (Pharmactive, Turkey) Under Fed Conditions
Status:
Completed
Trial end date:
2019-08-27
Target enrollment:
Participant gender:
Summary
OPEN-LABEL, RANDOMISED, SINGLE ORAL DOSE, FOUR-PERIOD, REPLICATED, CROSS-OVER TRIAL TO ASSESS
THE BIOEQUIVALENCE OF FENIRAMIDOL HCl 400 MG FILM TABLET (TEST DRUG) IN COMPARISON WITH
CABRAL 400 MG FILM TABLET (REFERENCE DRUG) IN HEALTHY MALE SUBJECTS UNDER FED CONDITIONS
Phase:
Phase 1
Details
Lead Sponsor:
Pharmactive Ilac Sanayi ve Tic A.S.
Collaborators:
Farmagen Ar-Ge Biyot. Ltd. Sti Novagenix Bioanalytical Drug R&D Center